These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23315164)
1. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164 [TBL] [Abstract][Full Text] [Related]
2. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527 [TBL] [Abstract][Full Text] [Related]
3. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling. Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509 [TBL] [Abstract][Full Text] [Related]
4. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis. Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876 [TBL] [Abstract][Full Text] [Related]
5. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767 [TBL] [Abstract][Full Text] [Related]
6. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874 [TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis. Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772 [TBL] [Abstract][Full Text] [Related]
8. Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Ostler KR; Yang Q; Looney TJ; Zhang L; Vasanthakumar A; Tian Y; Kocherginsky M; Raimondi SL; DeMaio JG; Salwen HR; Gu S; Chlenski A; Naranjo A; Gill A; Peddinti R; Lahn BT; Cohn SL; Godley LA Cancer Res; 2012 Sep; 72(18):4714-23. PubMed ID: 22815530 [TBL] [Abstract][Full Text] [Related]
9. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice. Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R J Biol Chem; 2021; 296():100285. PubMed ID: 33450231 [TBL] [Abstract][Full Text] [Related]
10. DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas. Alkebsi L; Handa H; Sasaki Y; Osaki Y; Yanagisawa K; Ogawa Y; Yokohama A; Hattori H; Koiso H; Saitoh T; Mitsui T; Tsukamoto N; Nojima Y; Murakami H Leuk Res; 2013 Dec; 37(12):1662-7. PubMed ID: 24094886 [TBL] [Abstract][Full Text] [Related]
11. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Hervouet E; Vallette FM; Cartron PF Epigenetics; 2009 Oct; 4(7):487-99. PubMed ID: 19786833 [TBL] [Abstract][Full Text] [Related]
12. Mutant mice lacking alternatively spliced p53 isoforms unveil Fajac A; Simeonova I; Leemput J; Gabriel M; Morin A; Lejour V; Hamon A; Rakotopare J; Vaysse-Zinkhöfer W; Eldawra E; Pinskaya M; Morillon A; Bourdon JC; Bardot B; Toledo F Elife; 2024 Sep; 13():. PubMed ID: 39298333 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735 [TBL] [Abstract][Full Text] [Related]
14. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Roll JD; Rivenbark AG; Jones WD; Coleman WB Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival. Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524 [TBL] [Abstract][Full Text] [Related]
16. Bim is a suppressor of Myc-induced mouse B cell leukemia. Egle A; Harris AW; Bouillet P; Cory S Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6164-9. PubMed ID: 15079075 [TBL] [Abstract][Full Text] [Related]